Biotechnology

  Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. NeuroSense Therapeutics Ltd. (...

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported positive topline results from the Phase 2 proof-of-concept study of its lead candidate LX9211 in painful diabetic neuropathy. The RELIEF-DPN-1 is the first of two Phase 2 proof-of-concept study designed to evaluate LX9211 in patients with neuropathic...

Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday. Piper Sandler reduced JOANN Inc. (NASDAQ: JOAN) price target from $11 to $6. JOANN shares fell 0.8% to $6.31 in pre-market trading. HC Wainwright & Co. lowered the price...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.89% to 32,953.50 while the NASDAQ fell 2.44% to 12,016.38. The S&P also fell, dropping, 1.52% to 4,113.52. Also check this: Home Depot And 2 Other Stocks...

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping more than 300 points on Friday. The Dow traded down 0.99% to 32,919.61 while the NASDAQ fell 2.61% to 11,995.68. The S&P also fell, dropping, 1.66% to 4,107.48. Also check this: Home Depot And 2 Other Stocks...

  Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Energy Focus, Inc. (NASDAQ: EFOI) shares jumped 32.8% to $1.4740 after declining around 9% on Thursday....

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.47% to 33,093.44 while the NASDAQ fell 1.49% to 12,132.82. The S&P also fell, dropping, 1% to 4,135.19. Also check this: Home Depot And 2...

Luna Innovations Inc (NASDAQ: LUNA) reported first-quarter FY22 revenue growth of 7% year-on-year to $22.5 million, beating the consensus of $21.2 million. Margins: The gross margin expanded 600 bps to 64%, driven primarily by a favorable product mix.  The operating margin...

Needham cut the price target on Carvana Co. (NYSE: CVNA) from $121 to $80. Carvana shares rose 11.3% to $42.71 in pre-market trading. Susquehanna cut Taboola.com Ltd. (NASDAQ: TBLA) price target from $10 to $3.5. Taboola.com shares fell 3% to $3.25 in pre-market trading. Wedbush raised the...

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday. ShiftPixy, Inc. (NASDAQ: PIXY) rose 21.5% to $0.6198 in pre-market trading after jumping 155% on Friday. Calyxt, Inc. (NASDAQ: CLXT) shares rose 21.4% to $0.4198 in...

Turning Point Therapeutics Inc (NASDAQ: TPTX) entered into an exclusive license agreement with LaNova Medicines Limited to develop and commercialize LM-302, in the U.S. and the rest of the world, excluding Greater China and South Korea.  LM-302 is a novel antibody-...

Gainers SoundHound AI, Inc. (NASDAQ: SOUN) rose 64.3% to $10.68 in pre-market trading after tumbling 13% on Friday. SoundHound had their IPO on Thursday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares rose 53.5% to $1.40 in pre-market trading following a 5% drop on Friday. Luokung Technology...

Turning Point Therapeutics Inc (NASDAQ: TPTX) announced topline results from the registrational TRIDENT-1 study of repotrectinib across all four ROS1-positive advanced non-small cell lung cancer (NSCLC) cohorts. In a total of 71 TKI-naïve advanced NSCLC population, the...

At the American College of Cardiology, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) highlighted a new data analysis from the SCORED Phase 3 trial of sotagliflozin in Type 2 diabetes and kidney disease patients. Sotagliflozin significantly reduced major adverse cardiovascular...

Ligand Pharmaceuticals Inc (NASDAQ: LGND) signed a merger agreement with Avista Public Acquisition Corp II (NASDAQ: AHPA), providing for the spin-off of OmniAb Inc. APHA is Avista Capital Partners-backed special purpose acquisition company (SPAC), and OmniAb is Ligand'...